Company intelligence / Profile preview

RUA Life Sciences

Irvine, Scotland, United Kingdomrualifesciences.com ↗

Ownership: Private
Employees: ~40
Development stage: Commercial

Overview

RUA Life Sciences provides next-generation implantable polymer technologies, notably Elast-Eon™, to the medical device industry. The company develops and manufactures vascular grafts, soft tissue patches, and tri-leaflet polymeric heart valves. It also licenses its proprietary polymers to third parties. Clinical results are not directly reported as the company is primarily a technology/platform provider rather than a therapeutics developer.

Therapeutic areas: OtherCardiovascular
Modalities: Polymer-based medical devicesBiologic-compatible polymers
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on RUA Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RUA Life Sciences.

Explore the full profile